Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints head of vaccines development

John Boslego will succeed Ralf Clemens

edit-Boslego-photo-2Takeda Pharmaceuticals has appointed John Boslego as senior vice president and head of development for its global vaccine business unit, effective from December 1.

He succeeds Ralf Clemens, who has served in the role since the launch of Takeda's vaccine business division in January 2012.

Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza. He will report to Rajeev Venkayya, president of Takeda's global vaccine business unit.

Commenting on the appointment, Venkayya said: “John brings a wealth of vaccine development and global health experience to Takeda at an important time.

“He takes the helm of an outstanding development team that was built by Ralf Clemens and I have the utmost confidence in their ability to deliver our exciting pipeline.”

Boslego has work in vaccine clinical research and development for over 40 years and was most recently director of the vaccine development global programme at PATH, where he built a vaccine development organisation and advanced vaccine development against illnesses including rotavirus, polio and meningococcus.

He has also served as executive director of biologics, clinical research at Merck & Co and prior to this, directed the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand.

14th October 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...